| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001066122A3 Herbal remedies for treating allergies and asthma |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001064214A3 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001034124A3 Use of 5ht-1a-serotonine receptor agonists for treating genetic or functional rhythm disorders in the respiratory system |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001029036A3 Allosteric sites on muscarinic receptors |
| 05/10/2002 | WO2001027135A3 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/10/2002 | WO2001023386A3 Benzodiazepin derivatives, the production and use thereof |
| 05/10/2002 | WO2001021203A9 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427613A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | CA2427589A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427394A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 05/10/2002 | CA2427194A1 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | CA2426992A1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 05/10/2002 | CA2426762A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |
| 05/09/2002 | WO2002036591A2 Inhalative solution formulation containing a tiotropium salt |
| 05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055543 Inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor; useful in treating diseases including asthma, arthritis, and sepsis. |
| 05/09/2002 | US20020055538 Aspirin-triggered lipid mediators |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055518 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 05/09/2002 | US20020055515 Contacting stimulated cells with a candidate compound which is an inhibitor of ATP binding to a P2Y- purinoceptor; and assaying said cells for release of one or more mediators. |
| 05/09/2002 | US20020055513 7-oxo-pyridopyrimidines (II) |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055494 Combinations of formoterol and mometasone furoate for asthma |
| 05/09/2002 | US20020055477 Immunomodulatory formulations and methods for use thereof |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020054907 Multiparticulate modified release composition |
| 05/09/2002 | US20020054880 Suppressing inflammatory response in mammal by the administration of lectin derived carbohydrate binding peptide capable of binding terminally linked alpha-sialic acid derivative |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1203764A1 Benzamidine derivatives with LTB4-antagonistic activity |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202984A1 Novel diphenyl-piperidine derivate |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 05/08/2002 | EP1202957A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/08/2002 | EP1202954A1 Novel aminobenzophenones |
| 05/08/2002 | EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 05/08/2002 | EP1202738A1 Dihydropyrazine derivatives as npy antagonists |
| 05/08/2002 | EP1202734A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202721A1 Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
| 05/08/2002 | EP1202628A1 Novel hypoxanthine and thiohypoxanthine compounds |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | DE10152369A1 Stable, propellant-free inhalable liquid medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium salt and antiallergic agent, antihistamine, steroid or leukotriene antagonist |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/08/2002 | CN1348460A Acetal Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 05/08/2002 | CN1348455A Pyrazolobenzodiazepines as CDK2 inhibitors |
| 05/08/2002 | CN1348453A Derivatives of pyrimido [6.1-a] isoquinolin-4-one |
| 05/08/2002 | CN1348452A Derivatives of pyrimido [6,1-a] isoquinolin -4-one |
| 05/08/2002 | CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 05/08/2002 | CN1348381A Treatment with small peptides to effect antifibrotic activity |
| 05/08/2002 | CN1348377A Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1348363A Novel pharmaceutical salt form |
| 05/08/2002 | CN1347727A Pharyngitis treating health taxad composition |
| 05/08/2002 | CN1347706A Cold and trachitis treating medicine decoction |
| 05/08/2002 | CN1347701A Seahorse powder capsule |
| 05/08/2002 | CN1084205C Medicine for treating disease of upper respiratory tract and its preparation |
| 05/07/2002 | US6384261 Treating endothelin-mediated disorders; inhibitory binding of endothilin peptides to eta and/or etb receptors; elucidating the physiological and pathophysiological roles and isolating endothelin receptors; antagonists |
| 05/07/2002 | US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 05/07/2002 | US6384222 N-benzenesulfonyl-L-proline compounds, preparation method and method for using the compounds in therapy |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384070 Restenosis, kidney diseases, lung diseases |
| 05/07/2002 | US6384047 Breathing disorders and hypotensive agents |
| 05/07/2002 | US6384041 Bicyclic sPLA2 inhibitors |
| 05/07/2002 | US6384038 Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| 05/07/2002 | US6383788 Minimizing thermally induced aggregation of DNase in solution with calcium |
| 05/07/2002 | US6383733 Methods of screening for pharmacologically active compounds for the treatment of tumour diseases |
| 05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
| 05/07/2002 | CA2145000C Compounds which are selective antagonists of the human nk3 receptor and their use as medicinal products and diagnostic tools |
| 05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034761A1 Pyranoside derivatives |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034721A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/02/2002 | WO2002034718A1 Amide derivatives as nmda receptor antagonists |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2002034270A1 Treatment of respiratory distress syndrome with powder surfactant composition |